Evidence map›Paper›PMID 34861215›Full record

ArticleThe American journal of pathology2022

Single-Cell Transcriptomics Reveal Disrupted Kidney Filter Cell-Cell Interactions after Early and Selective Podocyte Injury.

Abbe R Clark, Jamie Marshall, Yiming Zhou, Monica S Montesinos, Haiqi Chen, Lan Nguyen, Fei Chen, Anna Greka

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Podocyte Metabolic Reprogramming and Targeted Therapy.Journal of the American Society of Nephrology : JASN · 2026
    Review
  5. Article
  6. Review
  7. Podocytes in health and glomerular disease.Frontiers in cell and developmental biology · 2025
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Abbe R ClarkKidney Disease Initiative, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Jamie MarshallKidney Disease Initiative, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
Yiming ZhouKidney Disease Initiative, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Monica S MontesinosKidney Disease Initiative, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
Haiqi ChenKidney Disease Initiative, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
Lan NguyenKidney Disease Initiative, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
Fei ChenKidney Disease Initiative, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
Anna GrekaKidney Disease Initiative, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. Electronic address: agreka@bwh.harvard.edu.
Broad Institute · US

Funding

Molecular mechanisms of podocyte injury in FSGSR01DK095045 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Anna Greka, Juan Lorenzo Pablo · 2014 to 2026
$5.1M
Role of TRPC5 channel inhibition in the treatment of glomerular diseaseR01DK099465 · NIDDK · BROAD INSTITUTE, INC. · PI Anna Greka · 2014 to 2026
$5.1M
Optimization of novel inhibitors of TRPC5 as anti-proteinuric therapeuticsR01DK103658 · NIDDK · VANDERBILT UNIVERSITY · PI HOPKINS, COREY R. · 2014 to 2018
$1.7M
NIDDK NIH HHS R01 DK095045NIDDK NIH HHS R01 DK099465NIDDK NIH HHS R01 DK103658
6 · The paper itself

Abstract

The health of the kidney filtration barrier requires communication among podocytes, endothelial cells, and mesangial cells. Disruption of these cell-cell interactions is thought to contribute to disease progression in chronic kidney diseases (CKDs). Podocyte ablation via doxycycline-inducible deletion of an essential endogenous molecule, CTCF [inducible podocyte-specific CTCF deletion (iCTCF

Indexed as

Cell CommunicationPodocytesRenal Insufficiency, ChronicSingle-Cell AnalysisTranscriptomeAnimalsMiceMice, Knockout

Identifiers

PMID34861215
PMCPMC8892500
OpenAlexW3217211585

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.